OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/90/22/1a/90221aad-9b3d-59dc-87ee-1e482d6044f3/mza_8352392173652811543.jpg/600x600bb.jpg

P4A Let's Talk Rare: The Life Science Podcast

Partners4Access

104 episodes

1 week ago

Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable orphan drug access for patients with high unmet need, visit partners4access.com

Science

RSS

All content for P4A Let's Talk Rare: The Life Science Podcast is the property of Partners4Access and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/654908/654908-1751349086188-470d0d194602b.jpg

OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years

P4A Let's Talk Rare: The Life Science Podcast

27 minutes 44 seconds

4 months ago

OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years

Join us as we sit down with Paul Romness of OS Therapies to explore an exciting breakthrough in OST-HER2 targeted therapies for osteosarcoma—a rare and aggressive bone cancer.

Learn how this innovative approach is offering new hope to patients, advancing precision medicine, and pushing the boundaries of rare disease treatment, not just for humans but for dogs too.

Joining the discussion as always is host Owen Bryant, along with George Rack and guest presenter and P4A's MA Oncology expert, Rosa Maria Matthews.

Don’t miss this powerful conversation on the frontlines of rare cancer research.

Tune in now—because every rare voice matters.

#LetsTalkRare #Osteosarcoma #OSTHER2 #RareDisease #OSTherapies